Down Syndrome Obstructive Sleep Apnea Trial
Phase 2
230
about 4.2 years
5–18
7 sites in CA, MI, OH +3
What this study is about
Researchers are testing whether oxygen supplementation during sleep improves working memory and other clinical outcomes in children with Down Syndrome who have moderate to severe obstructive sleep apnea. The trial will last for 1528 days and involve approximately 230 participants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Oxygen
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
oxygen
Secondary: Patient-Reported Outcomes Measurement Information System (PROMIS) sleep disturbance T-score, Patient-Reported Outcomes Measurement Information System (PROMIS) sleep-related impairment T-score
Peds